Global Protein Therapeutics Market is Expected to Foresee Significant Growth. North America to lead the growth!

The global protein therapeutics market is expected to register a CAGR of around ~6.3% over the period of 2022-2028. Therapeutic proteins are medicines that are genetically engineered versions of naturally occurring human proteins. The growth of the protein therapeutics market is majorly driven by rising in the prevalence of chronic diseases and the development of plasma-derived therapies. Thus, an increase in the prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases is expected to drive the demand for protein therapeutics. According to National Cancer Institute, the incidence rates for cancer overall climb steadily as age increases, from fewer than 25 cases per 100,000 people in age groups under age 20 to about 350 per 100,000 people among those aged 45–49, to more than 1,000 per 100,000 people in age groups 60 years and older. Furthermore, various factors such as growing research and development activities are also expected to drive the demand for protein therapeutics over the forecast period which is responsible for the excessive use of protein and also significantly contributes to the market for the medical applications of protein therapeutics systems. Therefore, the market for protein therapeutics is expected to witness significant growth during the forecast period.

For a detailed analysis of the global protein therapeutics market browse through– https://univdatos.com/report/protein-therapeutics-market/

Based on application, the market is categorized into cancer, metabolic disorders, immunologic disorders, hematological disorders, and others. Among these, metabolic disorders are expected to witness the highest CAGR during the forecast period. A metabolic disorder is a group of conditions that together raise the risk of coronary heart disease, diabetes, stroke, and other serious health problems. Thus, Therapeutics protein refers to the ongoing biochemical processes that maintain the functioning of living organisms.

Based on end-user, the market is categorized into hospitals and clinics, specialty centers, and others. Among these, hospitals and clinics are expected to witness the highest CAGR during the forecast period. This is mainly due to the increase in the number of patients visiting hospitals with various chronic disorders The use of therapeutic proteins for manufacturing vaccines as they provide defense against autoimmune diseases, foreign agents, and cancer is likely to promote the market. Also, the hospitals and clinics are estimated to add to the growing need for protein therapeutics products which is expected to drive the growth of this segment.

Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=32561

For a better understanding of the market adoption of the protein therapeutics industry, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness the highest CAGR during the forecast period on account of the increasing incidence of cancer and surge in healthcare spending in countries like the U.S. and Canada. Moreover, the collective government initiatives and the intensifying concerns in terms of the safety and health of healthcare professionals are furthering the demand for protein therapeutics. The intensifying occurrence of cancer is one of the key factors accountable for the evolution of the protein therapeutics market in the forecast period. As per the American Cancer Society (2021), 1 in 3 people will be diagnosed with cancer in their lifetime. Furthermore, many medical and pharmaceutical companies are headquartered in the region, which is now focusing on research and development and clinical research activity for the treatment of cancer and various developmental strategies adopted by the regional market will drive market growth.

Some of the major players operating in the market include Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann La Roche Ltd, Johnson and Johnson, Merck and Co., Inc., Novo Nordisk AS, Pfizer Inc., Sanofi.

Global Protein Therapeutics Market Segmentation

Market Insight, by Type

• Monoclonal Antibodies
• Insulin
• Fusion Protein
• Erythropoietin
• Interferon
• Others

Market Insight, by Application

• Cancer
• Metabolic Disorders
• Immunologic Disorders
• Hematological Disorders
• Others

Market Insight, by Protein Function

• Enzymatic and Regulatory Activity
• Special Targeting Activity
• Vaccines
• Others

Market Insight, by End User

• Hospitals and Clinics
• Specialty Centers
• Others

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Abbott Laboratories
  • Amgen Inc.
  • Baxter International Inc.
  • Eli Lilly And Company
  • F. Hoffmann La Roche Ltd
  • Johnson and Johnson
  • Merck and Co., Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi